Betacellulin Protects From Pancreatitis by Activating Stress-Activated Protein Kinase

Gastroenterology

Volumn 138, Issue 4, 2010, Pages

  Dahlhoff, Maik ^a   Algül, Hana ^b   Siveke, Jens T ^b   Lesina, Marina ^b   Wanke, Rüdiger ^a   Wartmann, Thomas ^c   Halangk, Walter ^c   Schmid, Roland M ^b   Wolf, Eckhard ^a   Schneider, Marlon R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Betacellulin; ERBB4; Pancreatitis; SAPK

Indexed keywords

AMYLASE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ARGININE; BETACELLULIN; CERULETIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 4; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PANCREAS; PRIORITY JOURNAL; TISSUE NECROSIS; TRANSGENIC MOUSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; TURNOVER TIME;

EID: 77950210797     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.12.045     Document Type: Article

References (49)

1. Baron T.H., and Morgan D.E. Acute necrotizing pancreatitis. N Engl J Med 340 (1999) 1412-1417
2. Naruse S. Molecular pathophysiology of pancreatitis. Intern Med 42 (2003) 288-289
3. Granger J., and Remick D. Acute pancreatitis: models, markers, and mediators. Shock 24 Suppl 1 (2005) 45-51
4. Whitcomb D.C. Clinical practice. Acute pancreatitis. N Engl J Med 354 (2006) 2142-2150
5. Fiers W., Beyaert R., Declercq W., et al. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18 (1999) 7719-7730
6. Assuncao G.C., and Linden R. Programmed cell deaths. Apoptosis and alternative death styles. Eur J Biochem 271 (2004) 1638-1650
7. Edinger A.L., and Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16 (2004) 663-669
8. Kaiser A.M., Saluja A.K., Sengupta A., et al. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol 269 (1995) C1295-C1304
9. Gukovskaya A.S., Perkins P., Zaninovic V., et al. Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroenterology 110 (1996) 875-884
10. Saluja A., Hofbauer B., Yamaguchi Y., et al. Induction of apoptosis reduces the severity of caerulein-induced pancreatitis in mice. Biochem Biophys Res Commun 220 (1996) 875-878
11. Bhatia M., Wallig M.A., Hofbauer B., et al. Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis. Biochem Biophys Res Commun 246 (1998) 476-483
12. Bhatia M. Apoptosis versus necrosis in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 286 (2004) G189-G196
13. Gukovskaya A.S., and Pandol S.J. Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 4 (2004) 567-586
14. Halangk W., Lerch M.M., Brandt-Nedelev B., et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106 (2000) 773-781
15. Hughes C.B., Grewal H.P., Gaber L.W., et al. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 171 (1996) 274-280
16. Gukovskaya A.S., Gukovsky I., Zaninovic V., et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 100 (1997) 1853-1862
17. Kelly L., Reid L., and Walker N.I. Massive acinar cell apoptosis with secondary necrosis, origin of ducts in atrophic lobules and failure to regenerate in cyanohydroxybutene pancreatopathy in rats. Int J Exp Pathol 80 (1999) 217-226
18. Chen Y., Chong M.M., Darwiche R., et al. Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am J Pathol 165 (2004) 913-921
19. Mareninova O.A., Sung K.F., Hong P., et al. Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 281 (2006) 3370-3381
20. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2 (2001) 127-137
21. Sartor C.I., Zhou H., Kozlowska E., et al. Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol 21 (2001) 4265-4275
22. Vidal G.A., Naresh A., Marrero L., et al. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. J Biol Chem 280 (2005) 19777-19783
23. Kritzik M.R., Krahl T., Good A., et al. Expression of ErbB receptors during pancreatic islet development and regrowth. J Endocrinol 165 (2000) 67-77
24. Huotari M.A., Miettinen P.J., Palgi J., et al. ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology 143 (2002) 4437-4446
25. Srinivasan R., Poulsom R., Hurst H.C., et al. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol 185 (1998) 236-245
26. Kew T.Y., Bell J.A., Pinder S.E., et al. c-erbB-4 protein expression in human breast cancer. Br J Cancer 82 (2000) 1163-1170
27. Witton C.J., Reeves J.R., Going J.J., et al. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J Pathol 200 (2003) 290-297
28. Barnes N.L., Khavari S., Boland G.P., et al. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 11 (2005) 2163-2168
29. Schneider M.R., Dahlhoff M., Herbach N., et al. Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. Endocrinology 146 (2005) 5237-5246
30. Shing Y., Christofori G., Hanahan D., et al. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 259 (1993) 1604-1607
31. Riese D.J., Bermingham Y., van Raaij T.M., et al. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 12 (1996) 345-353
32. Lee D., Cross S.H., Strunk K.E., et al. Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor. Mamm Genome 15 (2004) 525-536
33. Dahlhoff M., Dames P.M., Lechner A., et al. Betacellulin overexpression in transgenic mice improves glucose tolerance and enhances insulin secretion by isolated islets in vitro. Mol Cell Endocrinol 299 (2009) 188-193
34. Algul H., Treiber M., Lesina M., et al. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J Clin Invest 117 (2007) 1490-1501
35. Charoenrat P., Wongkajornsilp A., Rhys-Evans P.H., et al. Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells. Int J Cancer 111 (2004) 174-183
36. Muraoka-Cook R.S., Caskey L.S., Sandahl M.A., et al. Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Mol Cell Biol 26 (2006) 6412-6424
37. Minutoli L., Altavilla D., Marini H., et al. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis. Life Sci 75 (2004) 2853-2866
38. Warzecha Z., Dembinski A., Konturek P.C., et al. Epidermal growth factor protects against pancreatic damage in cerulein-induced pancreatitis. Digestion 60 (1999) 314-323
39. Dembinski A., Warzecha Z., Konturek P.C., et al. Epidermal growth factor accelerates pancreatic recovery after caerulein-induced pancreatitis. Eur J Pharmacol 398 (2000) 159-168
40. Saito T., Okada S., Ohshima K., et al. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology 145 (2004) 4232-4243
41. Riese D.J., and Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20 (1998) 41-48
42. Sandgren E.P., Luetteke N.C., Palmiter R.D., et al. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61 (1990) 1121-1135
43. Jhappan C., Stahle C., Harkins R.N., et al. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61 (1990) 1137-1146
44. Wagner M., Luhrs H., Kloppel G., et al. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115 (1998) 1254-1262
45. Wagner M., Greten F.R., Weber C.K., et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 15 (2001) 286-293
46. Wagner M., Weber C.K., Bressau F., et al. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. Gastroenterology 122 (2002) 1898-1912
47. Krakowski M.L., Kritzik M.R., Jones E.M., et al. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J Endocrinol 162 (1999) 167-175
48. Means A.L., Ray K.C., Singh A.B., et al. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology 124 (2003) 1020-1036
49. Freeman M.L. Adverse outcomes of ERCP. Gastrointest Endosc 56 Suppl (2002) S273-S282